Clinical Trials
All Clinical Trials - Page 19 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05533632Phase 4Completed
Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
Semaglutide
- NCT05221229N/AActive Not Recruiting
Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )
Liraglutide
- NCT05260021Phase 3Completed
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Tirzepatide
- NCT05071898Phase 1Recruiting
Pharmacogenetics of Response to GLP1R Agonists
Semaglutide
- NCT05259033Phase 3Completed
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
Semaglutide
- NCT05230615N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
Semaglutide
- NCT05212857Phase 2Unknown
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Gonadorelin
- NCT05370235Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Afamelanotide
- NCT05207709Phase 3Terminated
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
Gonadorelin
- NCT04763564Phase 2Terminated
Efficacy of Liraglutide Therapy in Patients With IPAA
Liraglutide
- NCT05096065Phase 2Unknown
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
Gonadorelin
- NCT05286554Phase 4Completed
Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support
Gonadorelin
- NCT05553093Phase 4Recruiting
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Tirzepatide
- NCT04873245Phase 2Active Not Recruiting
Lifestyle Counseling and Medication for Adolescent Weight Management
Semaglutide
- NCT05254418Phase 2Completed
Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
Dulaglutide
- NCT05662189N/ARecruiting
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
Exenatide
- NCT05247268Phase 2Recruiting
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Gonadorelin
- NCT05249881EARLY_Phase 1Unknown
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
Semaglutide
- NCT05285397N/AUnknown
Effect of Liraglutide on Weight Loss in Patients Who Have Undergone Revisional Bariatric Surgeries.
Liraglutide
- NCT05303857Phase 4Completed
Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes
Semaglutide
- NCT05168774Phase 1/Phase 2Completed
FRDA Investigator Initiated Study (IIS) With Elamipretide
Elamipretide
- NCT05321511Phase 4Unknown
Comparison of Triggers in Double Ovarian Stimulation (DuoStim).
Gonadorelin
- NCT05439499Phase 3Unknown
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Gonadorelin
- NCT06301191N/AUnknown
The Effect of Semaglutide on Cardiovascular Markers and Liver Function
Semaglutide
- NCT07539584N/ACompleted
Adiponectin in Patients With Metabolic Disorders
Semaglutide
- NCT05131893N/ANot Yet Recruiting
Neoadjuvant Treatment of Breast Cancer
Gonadorelin
- NCT04854083Phase 4Unknown
Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
Semaglutide
- NCT05236517Phase 1Completed
A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity
Semaglutide
- NCT05251207N/AActive Not Recruiting
Plasma Trimethylamine N-oxide Elevation Induced by L-carnitine Supplementation and Insulin Resistance
Dsip
- NCT05227196Phase 1Completed
A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
Semaglutide
- NCT05136287N/ACompleted
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.
Semaglutide
- NCT05774119N/ACompleted
Effect of Coffee Consumption on Appetite Traits in Overweight and Obesity
Ghrp-6
- NCT04938388Phase 4Terminated
Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
Semaglutide
- NCT05218915Phase 4Completed
Basal Plus GLP1-ra on Glycemic Variability in CKD
Dulaglutide
- NCT05078255N/ACompleted
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
Semaglutide
- NCT05268627N/AUnknown
Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
Liraglutide
- NCT04487925Phase 4Unknown
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
Gonadorelin
- NCT05368857Phase 1Completed
DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers
Afamelanotide
- NCT05438810Phase 3Unknown
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
Gonadorelin
- NCT04307797Phase 4Completed
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
Exenatide
- NCT06229899N/ACompleted
Follistatin Levels in Metabolically Healthy and Unhealthy Obese Individuals
Follistatin
- NCT04873050Phase 4Recruiting
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
Semaglutide
- NCT06118203N/ACompleted
Semaglutide Use in Acute Pulmonary Embolism
Semaglutide
- NCT04979130Phase 4Completed
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
Semaglutide
- NCT05054361N/ARecruiting
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Ll-37
- NCT05184374N/AUnknown
Efficacy of Prolonged GnRH Test in Male Adolescents With Postoperative HH
Gonadorelin
- NCT04989946Phase 1/Phase 2Recruiting
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Gonadorelin
- NCT05857085Phase 4Completed
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
Semaglutide
- NCT05153564Phase 1Completed
A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause
Semaglutide
- NCT05173714Phase 2Recruiting
Sit Less, Interact and Move More (SLIMM) 2 Study
Semaglutide